Clinical Trial Update: Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda [Phase 3]

View source ↗

Summary

Phase 3 trial update examining nevirapine to prevent maternal-to-child HIV transmission in Uganda has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED